Principles of receptor interaction
The process of binding any pharmacological substance to a specific target is strictly governed by the law of mass action. Two processes constantly and concurrently take place in a biological system: the formation of the drug-receptor complex and its dissociation.
A state of dynamic equilibrium is reached at the moment when the rate of formation of new complexes becomes completely equal to the rate of their dissociation. Mathematically, this is expressed by the classical equation: $k_1 \cdot [B] \cdot [P] = k_2 \cdot [BP]$
Where:
- $[B]$ is the concentration of the free substance in the system;
- $[P]$ is the number of free receptors;
- $[BP]$ is the number of already bound complexes;
- $k_1$ and $k_2$ are the association and dissociation rate constants, respectively.
What is affinity and dissociation constant
Affinity (from the Latin term affinis, meaning "related") is the fundamental ability of a chemical substance to bind to a receptor. The physical meaning of this concept lies in the strength of the bond formed. The more reliable it is, the longer the complex exists prior to its natural dissociation.
A quantitative measure of this strength is the dissociation constant ($K_d$). It is calculated as the ratio of the dissociation rate constant to the association rate constant ($K_d = k_2 / k_1$). At equilibrium, the formula looks like this: $K_d = ([B] \cdot [P]) / [BP]$
Key pattern: the relationship between the $K_d$ value and affinity is strictly inversely proportional. The lower the $K_d$ value, the higher the affinity (the molecule binds more tightly). Conversely, the higher the $K_d$, the lower the affinity. For example, a drug with $K_d = 10^{-10}$ M has significantly higher affinity than a substance with $K_d = 10^{-3}$ M. This parameter is measured in moles per liter (M).
Fraction of occupied receptors and graphical analysis
To assess the scale of binding, the fraction of occupied receptors ($f$) is used. It demonstrates the ratio of bound receptors to their total number. The fraction can be calculated via concentration: $f = [B] / ([B] + K_d)$
This formula yields a crucial rule that reveals the physical meaning of $K_d$. If the concentration of the free substance is exactly equal to the dissociation constant ($[B] = K_d$), then the fraction of occupied receptors is exactly $1/2$ (or 0.5). Thus, $K_d$ is the concentration at which 50% of the available receptors in the system are occupied.
Graphically, the degree of binding is represented as a semi-logarithmic sigmoidal curve, where the Y-axis plots the percentage of binding and the X-axis plots the logarithm of concentration. If a substance's curve is shifted to the left, it means that it achieves 50% binding at a lower concentration, and therefore possesses a higher affinity for the receptor.
Intrinsic activity and pharmacological effect
High affinity guarantees reliable binding, but does not guarantee the development of the expected effect. For a biological response to occur, the substance must possess intrinsic activity. This is the molecule's ability, upon interaction with the receptor, to activate it and trigger a cascade of reactions. Depending on the presence of this property, all substances are divided into two large groups: agonists and antagonists.
The dissociation constant often correlates with the ultimate activity of the drug: a low $K_d$ usually implies a strong action. However, for a precise evaluation of the effect, the half-maximal effective concentration ($EC_{50}$) is used. This is the drug concentration that produces a half-maximal effect (50% of the maximum).
On the graph of effect intensity versus the logarithm of concentration, a similar logic applies: the lower the concentration required to achieve $EC_{50}$ (the curve is located further to the left), the higher the ultimate activity of the studied substance.
Briefly: answers to topical questions
How do agonists differ from antagonists in the context of intrinsic activity?
Agonists and antagonists differ in the presence or absence of the ability to elicit a biological response upon interaction with the receptor.
| Substance group | Intrinsic activity | Effect |
|---|---|---|
| Agonists | Present | Stimulate the receptor |
| Antagonists | Absent | Do not stimulate the receptor |
Agonists possess intrinsic activity. Antagonists have affinity, but are completely devoid of intrinsic activity. They bind to the receptor, creating an obstacle for endogenous ligands or exogenous agonists, while their effect is secondary and consists of eliminating the action of the natural stimulant.
What types of antagonists exist according to their mechanism of interaction with the receptor?
According to the mechanism of interaction with the receptor, competitive and non-competitive antagonists are distinguished.
- Competitive antagonists compete with agonists for binding sites and can displace them from receptor binding.
- Non-competitive antagonists bind to allosteric sites of the macromolecule or form stable covalent bonds.
In non-competitive antagonism, the conformation of the receptor changes, and it loses its ability to interact with the agonist. Increasing the agonist concentration in this case does not lead to a full restoration of the effect.
How to easily remember the relationship between affinity and Kd: imagine that Kd is the "price" for the receptor. The lower the "price" (smaller Kd value), the easier it is for the substance to "buy" a bond with it, and consequently, the higher its binding ability (affinity).
Class and exam questions
What units is the dissociation constant measured in?
The dissociation constant ($K_d$) is expressed in moles per liter (M). Numerically, it is equal to the concentration of the substance at which exactly half of the receptors in the system are occupied.
How are the Kd value and drug affinity related?
Their relationship is inversely proportional. The smaller the $K_d$ value, the higher the molecule's affinity for the receptor and the stronger their physical bond.
What is EC50 and how does this indicator differ from Kd?
$EC_{50}$ is the effective concentration that produces 50% of the maximum biological response (characterizes the effect). $K_d$, on the other hand, reflects exclusively binding strength (50% occupied receptors), regardless of the magnitude of the induced effect.
Is high affinity sufficient for the development of a pharmacological effect?
No, binding alone is not enough. The molecule must also possess intrinsic activity — the ability to stimulate the receptor after the complex is formed.
What else to study on this topic
- Classification of substances: differences between agonists and antagonists
- Factors determining the association and dissociation rate constants of the complex
- Practical application of semi-logarithmic binding curves
- Dependence of clinical dosing on Kd and EC50 parameters
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Affinity and Intrinsic Activity" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in "General Pharmacology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.